Nikolas K. Haass mainly investigates Melanoma, Cancer research, Cell biology, Cell culture and Protein kinase A. The concepts of his Melanoma study are interwoven with issues in Cadherin, Signal transduction, Cell adhesion, Cell cycle and Kinase. His study looks at the relationship between Cell cycle and fields such as Drug response, as well as how they intersect with chemical problems.
Nikolas K. Haass interconnects Cell growth, Apoptosis, Molecular biology, Cytotoxic T cell and Drug resistance in the investigation of issues within Cancer research. His study in Cell biology is interdisciplinary in nature, drawing from both Cancer cell, Cytoskeleton and Melanocyte. His Cell culture research is multidisciplinary, incorporating perspectives in Tropomyosin, Actin, Gene isoform and Actin cytoskeleton.
Melanoma, Cancer research, Cell biology, Cell cycle and Chemistry are his primary areas of study. His Melanoma research includes themes of Tumor microenvironment, Cancer cell, Apoptosis, Immunology and Microphthalmia-associated transcription factor. His Cancer research research is multidisciplinary, incorporating elements of Cancer, Metastasis, Cell culture, Drug resistance and In vivo.
His work carried out in the field of Cell biology brings together such families of science as Downregulation and upregulation and Melanocyte. His work on Cell cycle checkpoint as part of general Cell cycle research is frequently linked to Mathematical model, thereby connecting diverse disciplines of science. His studies deal with areas such as Flow cytometry and Cell growth as well as Cell.
The scientist’s investigation covers issues in Melanoma, Cancer research, Cell cycle, Biological system and Cell. His Melanoma research is multidisciplinary, relying on both Cancer cell, Phenotype, Microphthalmia-associated transcription factor and Cell biology. His Cancer research study combines topics in areas such as Cancer, Metastasis, Immune system and In vivo.
His work in the fields of Cell cycle, such as Cell cycle checkpoint, overlaps with other areas such as Mathematical model and Replicate. His research in Biological system intersects with topics in Cancer treatment and Melanoma cell line. JARID1B and Demethylase is closely connected to Cell growth in his research, which is encompassed under the umbrella topic of Cell.
His main research concerns Melanoma, Cancer research, Cancer, Biological system and Cell cycle. His Melanoma study integrates concerns from other disciplines, such as Phenotype, Cancer cell and Cell biology. His research in Cell biology focuses on subjects like Cell Plasticity, which are connected to Cell.
Nikolas K. Haass usually deals with Cancer research and limits it to topics linked to Apoptosis and Gemcitabine. His study on Metastasis is often connected to Bortezomib as part of broader study in Cancer. His biological study spans a wide range of topics, including Spheroid and Tumour spheroid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai;John T. Lee;Weiru Wang;Jiazhong Zhang.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases
Keiran S.M. Smalley;Nikolas K. Haass;Patricia A. Brafford;Mercedes Lioni.
Molecular Cancer Therapeutics (2006)
Adhesion, migration and communication in melanocytes and melanoma
Nikolas K. Haass;Keiran S. M. Smalley;Ling Li;Meenhard Herlyn.
Pigment Cell Research (2005)
An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells
Keiran S.M. Smalley;Rooha Contractor;Nikolas K. Haass;Angela N. Kulp.
Cancer Research (2007)
Normal human melanocyte homeostasis as a paradigm for understanding melanoma.
Nikolas K. Haass;Meenhard Herlyn.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research (2005)
The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel
Nikolas K Haass;Katrin Sproesser;Thiennga K Nguyen;Rooha Contractor.
Clinical Cancer Research (2008)
The Role of Altered Cell–Cell Communication in Melanoma Progression
Nikolas K Haass;Keiran S M Smalley;Meenhard Herlyn.
Journal of Molecular Histology (2003)
Targeting glutamine transport to suppress melanoma cell growth.
Qian Wang;Qian Wang;Kimberley A. Beaumont;Kimberley A. Beaumont;Nicholas J. Otte;Nicholas J. Otte;Josep Font;Josep Font.
International Journal of Cancer (2014)
PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas.
John T. Lee;Ling Li;Patricia A. Brafford;Marcia van den Eijnden.
Pigment Cell & Melanoma Research (2010)
Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion.
Keiran S.M. Smalley;Patricia Brafford;Nikolas K. Haass;Johanna M. Brandner.
American Journal of Pathology (2005)
Experimental Dermatology
(Impact Factor: 4.511)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Medical University of Vienna
University of Queensland
The Wistar Institute
Queensland University of Technology
University of Queensland
Australian National University
Harvard University
University of Sydney
RWTH Aachen University
Coventry University
University of Southern California
American University
Hunan University
KU Leuven
Northwestern University
Korea Research Institute of Standards and Science
Queen's University
Chuo University
University of British Columbia
University of California, Los Angeles
Karolinska University Hospital
Cleveland Clinic
Yale University
Universität Hamburg
Oregon National Primate Research Center
Boston University